Simple Summary Breast cancer is the most common cancer affecting women under 40 years
of age worldwide, with an increasing number of cases diagnosed each year. Despite this …

Precise definition of CIPN clinical features can be obtained by only using validated outcome
measures. Therefore, a major aim of clinical research is to standardize CIPN assessment …

Background: Cardiomyocytes are resistant to radiation. However, cardiac radiation exposure
causes coronary microvascular endothelial inflammation, a perturbation implicated in the …

Importance The increasing use of neoadjuvant systemic therapy (NST) has led to substantial
pathological complete response rates in patients with initially node-positive, early breast …

Purpose: The perturbation of metabolic pathways in high-grade bladder cancer has not
been investigated. We aimed to identify a metabolic signature in high-grade bladder cancer …

Purpose: Prognostic molecular assays may aid in treatment decisions for women with
estrogen receptor (ER)-positive, HER2-negative breast cancer. The prognostic value of a 12 …

Background: Not all breast cancer patients benefit from neoadjuvant or adjuvant therapy,
resulting in considerable undertreatment or overtreatment. New insights into the role of …

Background Long non-coding RNA (lncRNA) T-cell leukemia/lymphoma 6 (TCL6) has been
reported as a potential tumor suppressor. However, its expression and function in breast …

Background National cancer registries are valuable tools to analyze patterns of care and
clinical outcomes; yet, missing data may impact the accuracy and generalizability of these …

De-escalating adjuvant therapy following pathologic complete response (pCR) to an
abbreviated neoadjuvant regimen in human epidermal growth factor receptor 2-positive …